Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Postow

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Lancet (London, England)|September 13, 2022
Adjuvant checkpoint blockade following complete local therapy for melanoma metastasesJames W Smithy, Michael A Postow
The Lancet. Oncology|February 26, 2018
The brim of uncertainty in adjuvant treatment of melanomaAllison Betof Warner, Michael A Postow
The Lancet. Oncology|March 13, 2017
A step forward for patients with NRAS-mutant melanomaMichael A Postow, Paul B Chapman
Current Oncology Reports|June 5, 2012
Mucosal melanoma: pathogenesis, clinical behavior, and managementMichael A Postow, Omid Hamid, Richard D Carvajal
Cancer Journal (Sudbury, Mass.)|March 29, 2012
Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanomaMichael A Postow, James Harding, Jedd D Wolchok
The New England Journal of Medicine|January 11, 2018
Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeMichael A Postow, Robert Sidlow, Matthew D Hellmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Reply to M. Horiguchi et alDirk Schadendorf, Joel Jiang, Thomas Kelleher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology ResearchKelley M Kidwell, Michael A Postow, Katherine S Panageas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Immune Checkpoint Blockade in Cancer TherapyMichael A Postow, Margaret K Callahan, Jedd D Wolchok
Journal of the American Academy of Dermatology|August 21, 2022
Standardized guidelines for acral and nail unit melanoma treatment are lackingJulianne M Falotico, Michael A Postow, Shari R Lipner
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|September 13, 2022
Adjuvant checkpoint blockade following complete local therapy for melanoma metastasesJames W Smithy, Michael A Postow
The Lancet. Oncology|February 26, 2018
The brim of uncertainty in adjuvant treatment of melanomaAllison Betof Warner, Michael A Postow
The Lancet. Oncology|March 13, 2017
A step forward for patients with NRAS-mutant melanomaMichael A Postow, Paul B Chapman
Current Oncology Reports|June 5, 2012
Mucosal melanoma: pathogenesis, clinical behavior, and managementMichael A Postow, Omid Hamid, Richard D Carvajal
Cancer Journal (Sudbury, Mass.)|March 29, 2012
Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanomaMichael A Postow, James Harding, Jedd D Wolchok
The New England Journal of Medicine|January 11, 2018
Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeMichael A Postow, Robert Sidlow, Matthew D Hellmann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Reply to M. Horiguchi et alDirk Schadendorf, Joel Jiang, Thomas Kelleher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2017
Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology ResearchKelley M Kidwell, Michael A Postow, Katherine S Panageas
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Immune Checkpoint Blockade in Cancer TherapyMichael A Postow, Margaret K Callahan, Jedd D Wolchok
Journal of the American Academy of Dermatology|August 21, 2022
Standardized guidelines for acral and nail unit melanoma treatment are lackingJulianne M Falotico, Michael A Postow, Shari R Lipner
Pageof 22